Alexopoulos, G. S.
Abrams, P. C.
Young, R. C.
et al (1988) Cornell Scale for depression in dementia. Biological Psychiatry, 23, 271–284.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
American Psychiatric Association (1997) Practice guidelines for the treatment of Alzheimer's disease and other dementias of late life. American Journal of Psychiatry, 154 (suppl), 1–39.
Saxby, P. & Ehlert, K. (1987) Reality orientation and reminiscence therapy. A controlled cross-over study of elderly confused people. British Journal of Psychiatry, 151, 222–231.
Bowling, A. (1997) Research Methods in Health: Investigating Health and Health Services. Milton Keynes: Open University Press.
De Rotrou, J.
et al (1994) Cognitive stimulation of patients with dementia: preliminary results. International Journal of Geriatric Psychiatry, 9, 211–217.
Degun, G. & Maher, M. (1975) Reality orientation, a therapy for psychogeriatric patients: a controlled study. British Journal of Psychiatry, 127, 42–45.
Clare, L. & Woods, R. T. (2001) Cognitive Rehabilitation in Dementia. Hove: Psychology Press.
Anand, R. & Veach, J. (1998) A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate) in patients with mild to moderately severe Alzheimer's disease. ENA 713 B352 Study Group. International Journal of Geriatric Psychopharmacology, 1, 55–65.
Folstein, M. F.
Folstein, S. E. & McHugh, P. R. (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 2, 189–198.
Holden, U. P. & Woods, R. T. (1995) Positive Approaches to Dementia Care (3rd edn). Edinburgh: Churchill Livingstone.
Hughes, C. P.
Danziger, W. L.
et al (1982) A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566–572.
Kitwood, T. (1997) Dementia Reconsidered. Milton Keynes: Open University Press.
Knapp, M. J.
Knopman, D. S.
Soloman, P. R.
et al (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA, 271, 985–991.
Livingston, G. & Katona, C. (2000) How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis. International Journal of Geriatric Psychiatry, 15, 203–207.
Gibbons, L. E.
McCurry, S. M.
et al (1999) Quality of life in Alzheimer's disease: patient and caregiver reports. Journal of Mental Health and Aging, 5, 21–32.
Orrell, M. & Woods, B. (1996) Tacrine and psychological therapies in dementia – no contest? Editorial comment. International Journal of Geriatric Psychiatry, 11, 189–192.
Pattie, A. H. & Gilleard, C. J. (1979) Clifton Assessment Procedures for the Elderly (CAPE). Sevenoaks: Hodder & Stoughton.
Rogers, S. L.
Farlow, M. R.
Doody, R. S.
et al (1998) A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology, 50, 136–145.
Rosen, W. G.
Mohs, R. C. & Davis, K. L. (1984) A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356–1364.
et al (1999) Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ, 318, 633–638.
et al (1999) The development of a valid and reliable scale for anxiety in dementia. Aging and Mental Health, 3, 39–49.
et al (1998) Reality orientation for dementia: a review of the evidence for its effectiveness. Cochrane Library, issue 4. Oxford: Update Software.
et al (2000) Reality orientation for dementia: a systematic review of the evidence of effectiveness from randomised controlled trials. Gerontologist, 40, 206–212.
et al (2001) Can reality orientation be rehabilitated? Development and piloting of an evidence-based programme of cognition-based therapies for people with dementia. Neuropsychological Rehabilitation, 11, 377–397.
SPSS (2001) SPSS for Windows, Version 10. Chicago, IL: SPSS.
Taulbee, L. R. & Folsom, J. C. (1966) Reality orientation for geriatric patients. Hospital and Community Psychiatry, 17, 133–135.
et al (2003) Whose quality of life is it anyway? The validity and reliability of the Quality of Life – Alzheimer's Disease (QOL–AD) scale. Alzheimer's Disease and Associated Disorders, in press.
Vickers, A. J. & Altman, D. G. (2001) Analysing controlled trials with baseline and follow up measurements. BMJ, 323, 1123–1124.
Wilcock, G. K.
Lilienfeld, S. & Gaens, E. (2000) Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International Study Group. BMJ, 321, 1445–1449.
Woods, R. T. (1979) Reality orientation and staff attention: a controlled study. British Journal of Psychiatry, 134, 502–507.
Woods, R. T. (1996) Psychological therapies' in dementia. Handbook of the Clinical Psychology of Ageing (ed. R. T. Woods), pp. 575–600. Chichester: John Wiley & Sons.
Frisoni, G. B.
De Leo, D.
et al (1995) Reality orientation therapy in Alzheimer's disease: useful or not? A controlled study. Alzheimer's Disease and Associated Disorders, 9, 132–138.
Zarit, S. H.
Zarit, J. M. & Reever, K. E. (1982) Memory training for severe memory loss: effects on senile dementia patients and their families. Gerontologist, 22, 373–377.